Burjeel Holdings PLC · ADX:BURJEEL
Burjeel — EFG Conference 2023
33 slides from Burjeel's conference presentation, March 2023
Slide 1: Burjeel Holdings Investor Presentation – EFG Conference
Burjeel Holdings Investor Presentation – EFG Conference March 2023 1
Slide 2: Contents
Contents 1 Overview 2 Differentiated Business Model 3 FY 2022 Financial Update 4 Leading Operator in a Growing Market 5 Clearly Defined Growth Levers 6 Conclusion 2
Slide 3: Overview
Overview 3
Slide 4: Delivering quality healthcare at scale in MENA
Delivering quality healthcare at scale in MENA A leading private healthcare service provider in the UAE and MENA, operating an Integrated network across primary, secondary, tertiary and quaternary care AED 3.92bn AED 877.7m FY22 Revenue FY22 EBITDA UAE market leader in terms of in-patient market sha
Slide 5: High quality, large-scale portfolio of assets across geographies
High quality, large-scale portfolio of assets across geographies Segmental Revenue contribution (2022) Geographic Revenue contribution (2022) 2% 0.10% 88% 5% 10% Hospitals 8% 87% Abu Dhabi 10% & Al Ain Medical centres 88% 8% 2% Dubai & Pharmacies Northern Emirates 0.1% 5% 87% Oman Other # Number of
Slide 6: Differentiated Business Model
Differentiated Business Model 6
Slide 7: Leading brands targeting specific socio-economic demographic
Leading brands targeting specific socio-economic demographic Burjeel Medical City Other Burjeel assets Centre of Excellence Premium offering for Oncology and and expertise in Targeting industrial workers other complex complex cases Targeting the mid-market expat Targeting the mid to low-income Overv
Slide 8: Unique business model leveraging multiple touchpoints
Unique business model leveraging multiple touchpoints A full-scale hub-and-spoke model enables the Group to capture value across the entire patient pathway through multiple touchpoints – driving revenue, brand engagement Case in point | Patient journey for surgical treatment and Group loyalty. A A S
Slide 9: Channelling patients to complex specialities with higher yields
Channelling patients to complex specialities with higher yields Oncology Orthopaedics and Spine Women’s Care Paediatrics • Comprehensive cancer care • Largest orthopaedic practice in • Leading woman care provider, • Large infrastructure of 64 NICU1 network the UAE, with >2,800 ortho / with ~9,300 de
Slide 10: Strong growth in focus areas of complex care
Strong growth in focus areas of complex care The Group performed 57,866 surgeries and 4,998 complex procedures in 2022 643 378 147 Knee Replacement Cardiac Surgeries Hip Replacements in 2022 in 2022 in 2022 ▲ 29% (YoY) ▲ 26% ▲ 34% 1,022 1,749 1,059 Neurosurgeries Bariatric Surgeries ACL surgeries in
Slide 11: FY 2022 Financial Update
burjeel holdings FY 2022 Financial Update
Slide 12: Revenue and EBITDA
Revenue and EBITDA Revenues (AEDm)1 Commentary 17.1% ⚫ Group revenue increased by ~ 17.1% primarily driven by the hospitals segment on the back of ramp-up of Burjeel Medical City 3,924 as well as increase in revenue of other hospitals in growth phase 3,351 ⚫ Hospital segment has contributed 88.5%, v
Slide 13: Achieving strong financial performance
Achieving strong financial performance Patient Footfall Evolution (in 000's) Revenue Evolution (AED'm) EBITDA Evolution (AED'm) 2019A - 2022A CAGR 14.1% 2019A - 2022A CAGR 27.3% 2019A - 2022A CAGR 44.9% 5,573 4,858 4,283 123 3,959 105 92 3,924 878 87 779 3,351 2,421 2,605 470 5,450 418 4,192 4,753 3
Slide 14: Net profit
Net profit Net Profit (AEDm) Commentary 51.5% ⚫ Net profit increased by 51.5%, primarily due to the growth in revenue, increase in operational efficiencies and a reduction in depreciation and amortisation as compared to last year 355 ⚫ The hospital and medical centre segments were the major drivers
Slide 15: Financial summary FY2021 & FY2022
Financial summary FY2021 & FY2022 Group Financial Summary Segmental Financial Summary AED Million FY22 FY21 YoY % AED Millions FY22 FY21 YoY % Revenue 3,924 3,351 17% Revenue 3,924 3,351 17% 1 Opex -3,046 -2,572 18% Hospitals 3,472 2,942 18% EBITDA2 878 779 13% Medical Centers 381 347 10% Net Profit
Slide 16: Burjeel Medical City Performance
Burjeel Medical City Performance Total Patients (in 000s) Revenue (AEDm)1 EBITDA (AEDm) Commentary ⚫ Delivered 20% contribution to total hospital segment revenue 16.1% 28.8% (1.5)% 7.4% 33.7% 34.3% ⚫ Turned EBITDA positive in the current year 124.9% 1237.2% ⚫ Continued ramp up of BMC in current year
Slide 17: Group net working capital analysis
Group net working capital analysis Trade receivables (AEDm)1 Inventory (AEDm) Trade Account Payable (AEDm) 89 96 99 96 307 266 1,052 666 240 815 642 207 FY2021 FY2022 FY2021 FY2022 FY2021 FY2022 Days Sales Outstanding2 Days Inventory Outstanding3 Days Payables Outstanding4 ⚫ Receivable days remained
Slide 18: Group capital structure
Group capital structure Group Debt Commentary FY2021 FY2022 1⚫ Interest bearing loans and borrowings decreased by AED Bank Balances and Cash 134 150 1,947 million between Dec’21 to Dec’22, mainly as a result of the one-time settlement of loan liabilities amounting to 1 Interest bearing loans and bor
Slide 19: Leading Operator in a Growing Market
Leading Operator in a Growing Market 19
Slide 20: UAE healthcare expenditure primed for robust growth
UAE healthcare expenditure primed for robust growth Significant Growth Drivers UAE healthcare expenditure 50.0 60.0% Positive demographic trends driving healthcare demand 45.0 50.4% 50.4% 50.4% 49.0% 47.7% 47.7% 50.0% 1.4% 1.7% to 5.8% 40.0 Population Growth 60+ Population Share 35.0 34.0 CAGR betwe
Slide 21: UAE market leader with a prominent position across segments
UAE market leader with a prominent position across segments Solid market position and reputation Total UAE beds in 20212 unlocking growth opportunities 1,660 (2021 & 2022) 1,600 #1 inpatient platform in the UAE by 1,361 private market volume 1,400 1,200 1,000 1,000 927 923 Focus on specialized and c
Slide 22: Clearly Defined Growth Levers
Clearly Defined Growth Levers 22
Slide 23: Unique vision with multiple growth levers
Unique vision with multiple growth levers Ramp Up Of Increasing Operational Geographic Growth Assets Patient Yield Excellence Expansion Young asset fleet, with growth Elevate the delivery of Centralization and Deliver on our KSA entry to be driven by utilisation high-value complex care, digitization
Slide 24: A young asset fleet with growth to be driven by utilisation ramp-up
A young asset fleet with growth to be driven by utilisation ramp-up Asset maturity split for hospitals1 Inpatient bed occupancy2 16 hospitals 54% 56% 41% 19% 25% Matured FY2020 FY2021 FY2022 Growth - medium Growth - high 56% Group Outpatient utilisation3 71% 73% 65% We have significant headroom rema
Slide 25: Burjeel Medical City – the UAE leader in complex care
Burjeel Medical City – the UAE leader in complex care Overview 400 50+ Long Term Organ Beds Specialties Oncology Mother & Child Trauma & ER Care & Transplant Rehabilitation c. 14.8% 124 Lung Kidney Bone Marrow Heart Revenue Doctors Transplant Transplant Transplant Transplant Contribution1 Developmen
Slide 26: Burjeel Medical City – key driver of volume ramp up in Burjeel portfolio
Burjeel Medical City – key driver of volume ramp up in Burjeel portfolio Quarterly patient volumes (000s) Focus areas for volume growth A • Areas of focus to include oncology / Complex care nuclear medicine / foetal medicine / 90.9 advanced rehab / complex transplants • Strong focus on research supp
Slide 27: Middle East & Africa key regions of focus over the next 5 years
Middle East & Africa key regions of focus over the next 5 years, with Saudi Arabia core to growth strategy Multi-pronged strategy for Key region of focus – Middle East & Africa expansion into KSA O&M of hospitals / specialty centres Super-specialty centres Saudi Arabia (and other UAE neighbouring co
Slide 28: Leejam JV - Network of physiotherapy and wellness centers across KSA
Leejam JV - Network of physiotherapy and wellness centers across KSA Burjeel Holdings has entered into an agreement with Leejam Sports Company, the largest owner and operator of fitness centers in the GCC, to create a 50-50 Joint Venture Company that will establish and operate physiotherapy, rehabil
Slide 29: Management team with a wealth of industry and regional experience
Management team with a wealth of industry and regional experience Hari Mohan Haritas Safeer Ahamed Muhammed Shihabuddin Chief Financial Officer Chief Operating Officer Deputy Chief Finance Officer John Sunil Chief Executive Officer Appointed to position of CEO in September 2022, having been with Bur
Slide 30: Highly experienced Board of Directors
Highly experienced Board of Directors H.E. Ahmed Jasim Yousif Naser Alzaabi H.E. Dr Thani bin Ahmed Al Zeyoudi Vice Chairman, Non-Exec Director Non-Exec Director Dr Shamsheer Vayalil Founder and Chairman • Founded the group in 2007, and has driven its expansion into the leading healthcare platform i
Slide 31: Conclusion
Conclusion 32
Slide 32: Conclusion and key takeaways
Conclusion and key takeaways Burjeel Holdings Unique vision and strategy focused on STRATEGIC quality and clinical excellence VISION A HIGHLY DIFFERENTIATED ASSET, PRIMED FOR STRONG GROWTH Large, attractive and resilient growth markets ✓ Strong focus on education and research to drive clinical quali
Slide 33: Thank You
Thank You 34